MC

459.85

-1.08%↓

BNP

78.25

+0.48%↑

DB1.DE

256.1

+0.39%↑

NDA.FI

12.86

+0.78%↑

DIM

170.3

-0.9%↓

MC

459.85

-1.08%↓

BNP

78.25

+0.48%↑

DB1.DE

256.1

+0.39%↑

NDA.FI

12.86

+0.78%↑

DIM

170.3

-0.9%↓

MC

459.85

-1.08%↓

BNP

78.25

+0.48%↑

DB1.DE

256.1

+0.39%↑

NDA.FI

12.86

+0.78%↑

DIM

170.3

-0.9%↓

MC

459.85

-1.08%↓

BNP

78.25

+0.48%↑

DB1.DE

256.1

+0.39%↑

NDA.FI

12.86

+0.78%↑

DIM

170.3

-0.9%↓

MC

459.85

-1.08%↓

BNP

78.25

+0.48%↑

DB1.DE

256.1

+0.39%↑

NDA.FI

12.86

+0.78%↑

DIM

170.3

-0.9%↓

Search

Viscofan SA

Open

SectorFinance

60.3

Overview

Share price change

24h

Current

Min

60

Max

60.6

Key metrics

By Trading Economics

Income

-19M

31M

Sales

1.5M

307M

P/E

Sector Avg

17.23

25.916

EPS

0.685

Profit margin

10.206

Employees

5,480

EBITDA

-24M

65M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+19.24% upside

Dividends

By Dow Jones

Next Earnings

22 Oct 2025

Market Stats

By TradingEconomics

Market Cap

-42M

2.7B

Previous open

60.3

Previous close

60.3

News Sentiment

By Acuity

14%

86%

20 / 536 Finance

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Viscofan SA Chart

Past performance is not a reliable indicator of future results.

Related News

4 Aug 2025, 21:42 UTC

Earnings
Acquisitions, Mergers, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 Aug 2025, 21:21 UTC

Earnings
Major Market Movers

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 Aug 2025, 20:45 UTC

Earnings

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 Aug 2025, 19:15 UTC

Major Market Movers

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 Aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 Aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4 Aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4 Aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 Aug 2025, 21:30 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 21:21 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 Aug 2025, 21:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss $938M >RIG

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss/Shr $1.06 >RIG

4 Aug 2025, 20:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 Aug 2025, 20:15 UTC

Earnings

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 Aug 2025, 20:13 UTC

Earnings

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 Aug 2025, 20:09 UTC

Earnings

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 Aug 2025, 20:06 UTC

Earnings

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 Aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 Aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 Aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 Aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Peer Comparison

Price change

Viscofan SA Forecast

Price Target

By TipRanks

19.24% upside

12 Months Forecast

Average 72.5 EUR  19.24%

High 74 EUR

Low 71 EUR

Based on 2 Wall Street analysts offering 12 month price targets forViscofan SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

63.6 / 64.4Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

20 / 536 Finance

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Viscofan SA

Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings. The company offers cellulose casings for cooked, smoked, unsmoked, and dry-cured sausages. It provides collagen casings for processed and pre-cooked fried sausages, and dry-cured snacks, as well as provides collagen film cover for meat products under Total Control Net brand. In addition, the company offers fibrous casings under TITANIUM LINE brand; and transfer plastic casings under VISPICE brand. Further, it provides plastic casings, nanopack plastic films, and shrink bag related products. The company was incorporated in 1975 and is based in Tajonar, Spain.